For full functionality of this page it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser Food and Beverage Industry Category Archives
US Flag
UK Flag Canada Flag

Category: Food and Beverage Industry

Mar
19

Recalls During the COVID-19 Pandemic

First and foremost, we hope you and everyone close to you are well. We’re living through an unprecedented time and hopefully you’re able to find some calm and maintain connections. Like each of you, we’ve been working through the COVID-19 crisis, encouraging workers to follow the recommendations of federal, state and local health officials. But as crisis management professionals, we also can’t help but think about the long game.

Continue Reading
Mar
18

Future Cost of COVID-19 on Pharma Manufacturers

As the number of COVID-19 cases continue to increase worldwide, numerous questions and a tremendous amount of misinformation cloud the issue. Many remain confused about how the virus is transmitted, how dangerous it is, and what treatments for it may be available. The good news is that the safety of our food has been given a clean bill of health so far. Research indicates that food and food ingredients aren’t a transfer source for coronavirus.

Continue Reading
Feb
10

Preying on Fear, Activists Call for More Food Safety Regulation

In the aftermath of widespread romaine lettuce, flour, and chicken-strip recalls in 2019, the U.S. PIRG Education Fund is calling for upgrades to food-safety regulation in the 2020 edition of its food safety report, “How Safe is Our Food?” In most cases, regulations U.S. PIRG wants aren’t groundbreaking, and are already on the industry’s radar.

Continue Reading
Nov
13

Product Recalls Stabilize, But an Upsurge is Expected

While U.S. product recalls were relatively flat from the second to third quarter, expect an upsurge in the weeks and months to come as regulators – under growing pressure from Congress and consumer groups – turn their attention to currently unregulated categories.  Part of that pressure on regulators is a result of past handling of product safety issues.

Continue Reading
Nov
07

It’s Official: Active Pharmaceutical Ingredient Makers in FDA’s Crosshairs

If there was any doubt whether the entire active pharmaceutical ingredient (API) industry is a target for continued FDA scrutiny, it should be gone. Donald Ashley, director of FDA’s Office of Compliance, talked about major concerns the agency has with the API industry at the Association for Accessible Medicines’ conference. As reported in an

Continue Reading